MAPK8 and Hyperinsulinemia: Activation of SIRT1 improves glucose tolerance, lowers hyperinsulinemia, and increases systemic insulin sensitivity by significantly repressing the jun-n-terminal kinase (JNK) and inhibitor of NF-κB kinase (IKK) inflammatory pathways 37.